Literature DB >> 29019968

Fighting the fatty liver.

Liam Drew.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29019968     DOI： 10.1038/550S102a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH.

Authors:  Xiaoya Li; Jing Wang; Xue Gong; Meiling Zhang; Shuangshuang Kang; Bing Shu; Zuzhuang Wei; Zhi-Shu Huang; Ding Li
Journal:  Nucleic Acids Res       Date:  2020-09-04       Impact factor: 16.971

2.  Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.

Authors:  Yong Rao; Yu-Ting Lu; Chan Li; Qin-Qin Song; Yao-Hao Xu; Zhao Xu; Yu-Tao Hu; Hong Yu; Lin Gao; Lian-Quan Gu; Ji-Ming Ye; Zhi-Shu Huang
Journal:  Br J Pharmacol       Date:  2019-07-04       Impact factor: 8.739

3.  Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.

Authors:  Zhipeng Xu; Wenxin Hu; Bin Wang; Ting Xu; Jianning Wang; Dan Wei
Journal:  Yonsei Med J       Date:  2022-07       Impact factor: 3.052

4.  Hepatic subcellular distribution of squalene changes according to the experimental setting.

Authors:  Roberto Martínez-Beamonte; Olga Alda; Teresa Sanclemente; María J Felices; Sara Escusol; Carmen Arnal; Luis V Herrera-Marcos; Sonia Gascón; Joaquín C Surra; Jesús Osada; Mª Jesús Rodríguez-Yoldi
Journal:  J Physiol Biochem       Date:  2018-02-22       Impact factor: 4.158

5.  An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.

Authors:  Peng Zhao; Xiaoli Sun; Cynthia Chaggan; Zhongji Liao; Kai In Wong; Feng He; Seema Singh; Rohit Loomba; Michael Karin; Joseph L Witztum; Alan R Saltiel
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

6.  TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis.

Authors:  Jinchao Hou; Jue Zhang; Ping Cui; Yingyue Zhou; Can Liu; Xiaoliang Wu; Yun Ji; Sicong Wang; Baoli Cheng; Hui Ye; Liqi Shu; Kai Zhang; Di Wang; Jielin Xu; Qiang Shu; Marco Colonna; Xiangming Fang
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

7.  A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population.

Authors:  Narumi Muto; Kentaro Oniki; Miku Kudo; Yui Obata; Yuki Sakamoto; Naoto Tokumaru; Tomoko Izuka; Takehisa Watanabe; Koji Otake; Yasuhiro Ogata; Junji Saruwatari
Journal:  Diabetes Metab Syndr Obes       Date:  2020-02-12       Impact factor: 3.168

Review 8.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

9.  Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.

Authors:  Kuang-Tzu Huang; Kuang-Den Chen; Li-Wen Hsu; Chao-Pin Kung; Shu-Rong Li; Chien-Chih Chen; King-Wah Chiu; Shigeru Goto; Chao-Long Chen
Journal:  Nutrients       Date:  2020-01-20       Impact factor: 5.717

10.  Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis.

Authors:  Linlin Wang; Ting Jiao; Qiangqing Yu; Jialiang Wang; Luyao Wang; Gang Wang; Hao Zhang; Jianxin Zhao; Wei Chen
Journal:  Biomedicines       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.